AN2 Therapeutics, Inc. ANTX
NASDAQ · United States · Health Technology
$5.73+0.11 (+1.96%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.18 | -0.24 | +25.0% | $0 | — | +6.3%$5.91→$6.28 |
| Q4 2025 | 2026-03-17 | -0.29 | -0.24 | -20.8% | — | — | -1.5%$4.69→$4.62 |
| Q4 2024 | 2025-03-25 | -0.25 | -0.25 | 0.0% | — | — | — |
| Q4 2023 | 2024-03-28 | -0.57 | -0.74 | +23.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.